TuHURA Biosciences, Inc./NV
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
HURA | US
Overview
Corporate Details
- ISIN(s):
- US49720K1016
- LEI:
- Country:
- United States of America
- Address:
- 10500 UNIVERSITY CENTER DR., 33612 TAMPA
- Website:
- https://tuhurabio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company focused on developing novel technologies and therapeutics to overcome primary and acquired resistance to cancer immunotherapies. The company's core mission is to address the challenges of treatment resistance in cancer patients. Its pipeline is built upon distinct technology platforms, including the IMMUNE FX (IFX) innate immune agonist, designed to enhance the efficacy of existing and new cancer treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TuHURA Biosciences, Inc./NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TuHURA Biosciences, Inc./NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TuHURA Biosciences, Inc./NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
